Primary Site >> Stomach Cancer

Gene >> PAK2

Journal: J Proteome Res. 2012 Apr 6;11(4):2355-64.
Title: Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.
Author: Cho, Hee Jun|Baek, Kyoung Eun|Kim, In-Kyu|Park, Sun-Mi|Choi, Yeong-Lim|Nam, In-Koo|Park, Seung-Ho|Im, Min-Ju|Yoo, Jong-Min|Ryu, Ki-Jun|Oh, Young Taek|Hong, Soon-Chan|Kwon, Oh-Hyung|Kim, Jae Won|Lee, Chang Won|Yoo, Jiyun
PMID: 22364609
Journal: Int J Cancer. 2014 Feb 15;134(4):822-31.
Title: Genetic variants in fas signaling pathway genes and risk of gastric cancer.
Author: Hyland, Paula L|Lin, Shih-Wen|Hu, Nan|Zhang, Han|Wang, Lemin|Su, Hua|Wang, Chaoyu|Ding, Ti|Tang, Ze-Zhong|Fan, Jin-Hu|Qiao, You-Lin|Xiong, Xiaoqin|Wheeler, William|Giffen, Carol|Yu, Kai|Yuenger, Jeff|Burdett, Laurie|Wang, Zhaoming|Chanock, Stephen J|Tucke
PMID: 23921907
Journal: Diagn Pathol. 2014 Mar 12;9:55.
Title: Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.
Author: Gao, Chengcheng|Ma, Tianheng|Pang, Liqun|Xie, Rui
PMID: 24621074